$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Exclusive: Evolent Health in sale talks after inbound interest, sources say
01:22pm, Thursday, 22'nd Aug 2024
Evolent Health is in talks with private equity firms and other companies for a potential sale, in a process that kicked off after the healthcare services provider received inbound interest, people fam
Evolent Health (EVH) Reports Q2 Earnings: What Key Metrics Have to Say
10:30am, Friday, 09'th Aug 2024
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics comp
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
09:18pm, Thursday, 08'th Aug 2024
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Evolent Health (EVH) Surpasses Q2 Earnings and Revenue Estimates
06:31pm, Thursday, 08'th Aug 2024
Evolent Health (EVH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.14 per share a year ago.
Evolent Announces Second Quarter 2024 Results
04:10pm, Thursday, 08'th Aug 2024
Revenue of $647.1 million, an increase of $178.0 million or 37.9%, from the three months ended June 30, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and
3 Top Tech Stocks Ready for Robust Gains
06:46am, Sunday, 04'th Aug 2024
Investors must always balance growth and stability in their portfolios. While employing defensive positions is essential, deploying capital in high-growth sectors like technology can be a formula that
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
08:45am, Wednesday, 17'th Jul 2024
Evolent Health (EVH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ter
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
08:00am, Thursday, 11'th Jul 2024
Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex
Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify
07:00am, Tuesday, 04'th Jun 2024
Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation Machinify techno
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
10:30am, Friday, 10'th May 2024
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics com
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
07:51pm, Thursday, 09'th May 2024
Evolent Health (EVH) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
04:15pm, Thursday, 09'th May 2024
Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comp
Evolent Announces First Quarter 2024 Results
04:10pm, Thursday, 09'th May 2024
Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million a
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
04:30pm, Thursday, 18'th Apr 2024
Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with comple
Does Evolent Health (EVH) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?
10:56am, Thursday, 14'th Mar 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 34.5% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the
Sign In
Buy EVH